+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gastrointestinal Cancer"

From
Oncology Nutrition - Global Strategic Business Report - Product Thumbnail Image

Oncology Nutrition - Global Strategic Business Report

  • Report
  • May 2024
  • 352 Pages
  • Global
From
Intussusception Global Market Report 2024 - Product Thumbnail Image

Intussusception Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
Oncology Nutrition Global Market Report 2024 - Product Thumbnail Image

Oncology Nutrition Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
From
Cancer Cachexia Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cancer Cachexia Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 145 Pages
  • Global
From
From
From
Gastro-esophageal Adenocarcinoma - Epidemiology Forecast - 2030 - Product Thumbnail Image

Gastro-esophageal Adenocarcinoma - Epidemiology Forecast - 2030

  • Report
  • February 2021
  • 100 Pages
  • Global
From
From
From
From
PARP Inhibitors in Oncology - Product Thumbnail Image

PARP Inhibitors in Oncology

  • Report
  • September 2018
  • 116 Pages
  • Global
From
Loading Indicator

Gastrointestinal cancer is a type of cancer that affects the digestive system, including the stomach, small intestine, colon, rectum, liver, gallbladder, pancreas, and bile ducts. It is the most common type of cancer in the world, and is the second leading cause of cancer-related deaths. Gastroenterology is the branch of medicine that focuses on the diagnosis and treatment of diseases of the digestive system. Gastroenterologists are often the first line of defense in diagnosing and treating gastrointestinal cancer. Gastrointestinal cancer is typically treated with a combination of surgery, chemotherapy, and radiation therapy. In some cases, targeted therapies, such as immunotherapy, may be used. The prognosis for gastrointestinal cancer depends on the stage of the cancer, the type of cancer, and the patient's overall health. There are many companies in the gastrointestinal cancer market, including AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Roche, and Sanofi. These companies develop and market drugs and treatments for gastrointestinal cancer, as well as provide support services for patients and their families. Show Less Read more